 |
|
Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease
Derek S. Larson, Daniel W. Coyne
Kidney Res Clin Pract. 2013;32(1):11-15. Published online 2013 Jan 16 DOI: https://doi.org/10.1016/j.krcp.2013.01.001
|
|
Citations to this article as recorded by
 Insights into the molecular mechanisms of malnutrition‐associated steatohepatitis: A review
Vinesh Sharma, Vikram Patial
Liver International.2024;[Epub] CrossRef Narrative Review of Hyperferritinemia, Iron Deficiency, and the Challenges of Managing Anemia in Aboriginal and Torres Strait Islander Australians With CKD
Sandawana William Majoni, Paul D. Lawton, Geetha Rathnayake, Federica Barzi, Jaquelyne T. Hughes, Alan Cass
Kidney International Reports.2021; 6(2): 501. CrossRef In-depth review: is hepcidin a marker for the heart and the kidney?
Rengin Elsurer Afsar, Mehmet Kanbay, Avsin Ibis, Baris Afsar
Molecular and Cellular Biochemistry.2021; 476(9): 3365. CrossRef INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial
Sandawana William Majoni, Jane Nelson, Darren Germaine, Libby Hoppo, Stephanie Long, Shilpa Divakaran, Brandon Turner, Jessica Graham, Sajiv Cherian, Basant Pawar, Geetha Rathnayake, Bianca Heron, Louise Maple-Brown, Robert Batey, Peter Morris, Jane Davie
Trials.2021;[Epub] CrossRef Anemia after kidney transplantation: Does its basis differ from anemia in chronic kidney disease?
Çiğdem Oruç, Nur Canpolat, Esra Pehlivan, Özlem Balcı Ekmekçi, Ayşe Ağbaş, Salim Çalışkan, Fatma Lale Sever
Pediatric Transplantation.2020;[Epub] CrossRef Estudio de la ferropenia en el laboratorio clínico
D. Pérez Surribas, A. Gella Concustell, E. Cruz Iglesias, S. Hermoso Durán, E. Urrechaga Igartua, M.J. Alcaide Martín, A. Merino González
Revista del Laboratorio Clínico.2019; 12(4): e34. CrossRef Working Toward an Improved Understanding of Chronic Cardiorenal Syndrome Type 4
Daniel Edmonston, Jessica D. Morris, John P. Middleton
Advances in Chronic Kidney Disease.2018; 25(5): 454. CrossRef Reply
Bernd Froessler, Peter Palm, Ingo Weber, Nicolette A. Hodyl, Rajvinder Singh, Elizabeth M. Murphy
Annals of Surgery.2018; 267(3): e49. CrossRef Treatment of renal anemia: Erythropoiesis stimulating agents and beyond
Patrick Biggar, Gheun-Ho Kim
Kidney Research and Clinical Practice.2017; 36(3): 209. CrossRef Assessing the Association between Serum Ferritin, Transferrin Saturation, and C-Reactive Protein in Northern Territory Indigenous Australian Patients with High Serum Ferritin on Maintenance Haemodialysis
Sandawana William Majoni, Paul D. Lawton, Federica Barzi, Alan Cass, Jaquelyne T. Hughes
International Journal of Nephrology.2017; 2017: 1. CrossRef Altered Metabolism of Blood Manganese Is Associated with Low Levels of Hemoglobin in Patients with Chronic Kidney Disease
Minyoung Kim, Eun Koh, Sungjin Chung, Yoon Chang, Seok Shin
Nutrients.2017; 9(11): 1177. CrossRef Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial
Alhossain A Khalafallah, Carl Yan, Raghad Al-Badri, Ella Robinson, Brooke E Kirkby, Emily Ingram, Zara Gray, Vinod Khelgi, Iain K Robertson, Brian P Kirkby
The Lancet Haematology.2016; 3(9): e415. CrossRef Utilisation des dérivés injectables du fer au cours de la maladie rénale chronique : intérêts, limites et conseils pour un bon usage
Jacques Rottembourg, Guy Rostoker
Néphrologie & Thérapeutique.2015; 11(7): 531. CrossRef
|